FDA Says Avastin Not Safe or Effective for Patients With Breast Cancer
Avastin® (bevacizumab) Clinical Trials | NSCLC Treatment
MAPLE Trial | MVASI® vs. Avastin®
Avastin (bevacizumab) - Angiogenesis Inhibitor and Cancer Therapy - Clinical Trials Arena
Avastin® (bevacizumab) Clinical Trials for Ovarian Cancer | HCP
Celltrion unveils P3 study results of Avastin biosimilar at US cancer meet < Bio < 기사본문 - KBR
MAPLE Trial | MVASI® vs. Avastin®
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer | NEJM
A New Day Dawns For Avastin I Pharma Intelligence
PAOLA-1 Phase 3 Trial – LYNPARZA® (olaparib) + Bevacizumab for Advanced Ovarian Cancer
Breakthrough from PAOLA1 GINECO/ENgOT-ov25 trial
Avastin® (bevacizumab) Clinical Trials | NSCLC Treatment
Avastin® (bevacizumab) Clinical Trials | rGBM Treatment
IMbrave150 Clinical Trial Study Design | TECENTRIQ® (atezolizumab)
A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group -
Avastin had its breast cancer approval revoked by FDA
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook - Cancer Treatment Reviews
Clinical and Regulatory Considerations for the Use of Bevacizumab Biosimilars in Metastatic Colorectal Cancer - Clinical Colorectal Cancer
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma | NEJM
Avastin® (bevacizumab) Clinical Trials | MCRC Treatment
Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies - Field - 2015 - Cancer - Wiley Online Library
Clinical and Regulatory Considerations for the Use of Bevacizumab Biosimilars in Metastatic Colorectal Cancer
